Annual Cash & Cash Equivalents:
$2.58B-$144.70M(-5.31%)Summary
- As of today, DXCM annual cash & cash equivalents is $2.58 billion, with the most recent change of -$144.70 million (-5.31%) on December 31, 2024.
- During the last 3 years, DXCM annual cash & cash equivalents has fallen by -$151.80 million (-5.56%).
- DXCM annual cash & cash equivalents is now -5.56% below its all-time high of $2.73 billion, reached on December 31, 2021.
Performance
DXCM Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$3.32B+$392.80M(+13.41%)Summary
- As of today, DXCM quarterly cash & cash equivalents is $3.32 billion, with the most recent change of +$392.80 million (+13.41%) on September 30, 2025.
- Over the past year, DXCM quarterly cash & cash equivalents has increased by +$829.80 million (+33.29%).
- DXCM quarterly cash & cash equivalents is now -8.64% below its all-time high of $3.64 billion, reached on June 30, 2023.
Performance
DXCM Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DXCM Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -5.3% | +33.3% |
| 3Y3 Years | -5.6% | +40.1% |
| 5Y5 Years | +68.2% | +27.6% |
DXCM Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -5.6% | +5.0% | -8.6% | +40.1% |
| 5Y | 5-Year | -5.6% | +68.2% | -8.6% | +40.1% |
| All-Time | All-Time | -5.6% | >+9999.0% | -8.6% | >+9999.0% |
DXCM Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $3.32B(+13.4%) |
| Jun 2025 | - | $2.93B(+8.4%) |
| Mar 2025 | - | $2.70B(+4.7%) |
| Dec 2024 | $2.58B(-5.3%) | $2.58B(+3.5%) |
| Sep 2024 | - | $2.49B(-20.1%) |
| Jun 2024 | - | $3.12B(+7.7%) |
| Mar 2024 | - | $2.90B(+6.3%) |
| Dec 2023 | $2.72B(+10.9%) | $2.72B(-15.9%) |
| Sep 2023 | - | $3.24B(-10.9%) |
| Jun 2023 | - | $3.64B(+41.7%) |
| Mar 2023 | - | $2.57B(+4.5%) |
| Dec 2022 | $2.46B(-10.1%) | $2.46B(+3.6%) |
| Sep 2022 | - | $2.37B(-13.9%) |
| Jun 2022 | - | $2.75B(+2.5%) |
| Mar 2022 | - | $2.69B(-1.6%) |
| Dec 2021 | $2.73B(+0.9%) | $2.73B(+1.2%) |
| Sep 2021 | - | $2.70B(+4.4%) |
| Jun 2021 | - | $2.58B(-1.8%) |
| Mar 2021 | - | $2.63B(-2.8%) |
| Dec 2020 | $2.71B(+76.6%) | $2.71B(+4.0%) |
| Sep 2020 | - | $2.60B(+3.8%) |
| Jun 2020 | - | $2.51B(+66.1%) |
| Mar 2020 | - | $1.51B(-1.5%) |
| Dec 2019 | $1.53B(+10.7%) | $1.53B(+7.2%) |
| Sep 2019 | - | $1.43B(+3.8%) |
| Jun 2019 | - | $1.38B(+1.4%) |
| Mar 2019 | - | $1.36B(-2.0%) |
| Dec 2018 | $1.39B(+152.6%) | $1.39B(+107.2%) |
| Sep 2018 | - | $668.70M(+10.3%) |
| Jun 2018 | - | $606.10M(+13.5%) |
| Mar 2018 | - | $533.90M(-2.7%) |
| Dec 2017 | $548.60M(+343.5%) | $548.60M(+4.3%) |
| Sep 2017 | - | $525.80M(+5.9%) |
| Jun 2017 | - | $496.60M(+174.2%) |
| Mar 2017 | - | $181.10M(+46.4%) |
| Dec 2016 | $123.70M(+7.4%) | $123.70M(-2.8%) |
| Sep 2016 | - | $127.30M(+10.1%) |
| Jun 2016 | - | $115.60M(+8.5%) |
| Mar 2016 | - | $106.50M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $115.20M(+37.8%) | $115.20M(+1.7%) |
| Sep 2015 | - | $113.30M(+16.2%) |
| Jun 2015 | - | $97.50M(+16.3%) |
| Mar 2015 | - | $83.80M(+0.2%) |
| Dec 2014 | $83.60M(+53.1%) | $83.60M(+11.6%) |
| Sep 2014 | - | $74.90M(+22.2%) |
| Jun 2014 | - | $61.30M(+6.8%) |
| Mar 2014 | - | $57.40M(+5.1%) |
| Dec 2013 | $54.60M(+12.1%) | $54.60M(+14.7%) |
| Sep 2013 | - | $47.60M(+2.6%) |
| Jun 2013 | - | $46.40M(+2.4%) |
| Mar 2013 | - | $45.30M(-7.0%) |
| Dec 2012 | $48.70M(+0.3%) | $48.70M(-8.8%) |
| Sep 2012 | - | $53.38M(-12.8%) |
| Jun 2012 | - | $61.19M(-12.8%) |
| Mar 2012 | - | $70.18M(-27.9%) |
| Sep 2011 | - | $97.32M(-8.2%) |
| Jun 2011 | - | $106.02M(+118.4%) |
| Dec 2010 | $48.55M(-24.5%) | $48.55M(+53.8%) |
| Sep 2010 | - | $31.57M(-21.2%) |
| Jun 2010 | - | $40.08M(-19.7%) |
| Mar 2010 | - | $49.92M(+31.9%) |
| Jun 2008 | - | $37.86M(-25.2%) |
| Mar 2008 | - | $50.58M(-21.4%) |
| Dec 2007 | $64.32M(+254.1%) | $64.32M(-13.4%) |
| Sep 2007 | - | $74.28M(-11.8%) |
| Jun 2007 | - | $84.20M(-9.6%) |
| Mar 2007 | - | $93.18M(+44.1%) |
| Dec 2006 | $18.17M(-51.2%) | - |
| Sep 2006 | - | $64.68M(+169.7%) |
| Jun 2006 | - | $23.98M(+18.8%) |
| Mar 2006 | - | $20.18M(-45.8%) |
| Dec 2005 | $37.25M(+36.8%) | $37.25M(-11.6%) |
| Sep 2005 | - | $42.12M(-18.2%) |
| Jun 2005 | - | $51.49M(+1008.7%) |
| Mar 2005 | - | $4.64M |
| Dec 2004 | $27.23M(+36.0%) | - |
| Dec 2003 | $20.02M(+157.4%) | - |
| Dec 2001 | $7.78M(-44.0%) | - |
| Dec 2000 | $13.90M | - |
FAQ
- What is DexCom, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for DexCom, Inc.?
- What is DexCom, Inc. annual cash & cash equivalents year-on-year change?
- What is DexCom, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for DexCom, Inc.?
- What is DexCom, Inc. quarterly cash & cash equivalents year-on-year change?
What is DexCom, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of DXCM is $2.58B
What is the all-time high annual cash & cash equivalents for DexCom, Inc.?
DexCom, Inc. all-time high annual cash & cash equivalents is $2.73B
What is DexCom, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, DXCM annual cash & cash equivalents has changed by -$144.70M (-5.31%)
What is DexCom, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DXCM is $3.32B
What is the all-time high quarterly cash & cash equivalents for DexCom, Inc.?
DexCom, Inc. all-time high quarterly cash & cash equivalents is $3.64B
What is DexCom, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, DXCM quarterly cash & cash equivalents has changed by +$829.80M (+33.29%)